Connection

Carmen Suárez Fernández to Kaplan-Meier Estimate

Back to Details
This is a "connection" page, showing publications Carmen Suárez Fernández has written about Kaplan-Meier Estimate.
Carmen Suárez Fernández
Connection Strength
0.065
Kaplan-Meier Estimate
  1. Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nat Med. 2018 06; 24(6):749-757.
    View in: PubMed
    Score: 0.023
  2. Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma. Oncotarget. 2017 May 02; 8(18):30410-30421.
    View in: PubMed
    Score: 0.021
  3. Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib. Sci Rep. 2017 01 24; 7:41371.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.